Amarin Corp Plcuk (AMRN) Change in Inventory (2012 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Change in Inventory of -$12.3 million for Q1 2026, up 11.29% YoY from -$11.1 million in Q1 2025, and down 686.63% sequentially from $2.1 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Change in Inventory (2012 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Change in Inventory across 15 years of filings, most recently posting -$12.3 million for Q1 2026.

  • In Q1 2026, Change in Inventory rose 11.29% year-over-year to -$12.3 million; the TTM figure through Mar 2026 stood at -$33.3 million (up 70.42% YoY), while the FY2025 annual figure was -$34.9 million, up 66.92% from the prior year.
  • Change in Inventory slipped to -$12.3 million in Q1 2026, from $2.1 million in the prior quarter.
  • Over the last five years, Change in Inventory for AMRN reached as high as $52.9 million in Q1 2022 and fell as low as -$67.2 million in Q4 2024.
  • The 5-year median for Change in Inventory is -$12.7 million (2024), against an average of -$10.1 million.
  • Annual changes were most pronounced in 2024 — Change in Inventory slumped 570.87% — and 2025, when it surged 103.12%.
  • A 5-year view of Change in Inventory shows it stood at -$23.2 million in 2022, then jumped by 56.84% to -$10.0 million in 2023, then tumbled by 570.87% to -$67.2 million in 2024, then jumped by 103.12% to $2.1 million in 2025, then sank by 686.63% to -$12.3 million in 2026.
  • According to Business Quant data, Change in Inventory over the past three periods registered -$12.3 million, $2.1 million, and -$17.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 431.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 184.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -18.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 52.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -12.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.33 Mn
Mar 31, 2026 -12.33 Mn
Dec 31, 2025 2.10 Mn
Dec 31, 2025 2.10 Mn
Sep 30, 2025 -17.02 Mn
Sep 30, 2025 -17.02 Mn
Jun 30, 2025 -6.06 Mn
Jun 30, 2025 -6.06 Mn
Mar 31, 2025 -13.89 Mn
Mar 31, 2025 -13.89 Mn
Dec 31, 2024 -67.24 Mn
Dec 31, 2024 -67.24 Mn
Sep 30, 2024 -12.68 Mn
Sep 30, 2024 -12.68 Mn
Jun 30, 2024 -18.80 Mn
Jun 30, 2024 -18.80 Mn
Mar 31, 2024 -6.73 Mn
Mar 31, 2024 -6.73 Mn
Dec 31, 2023 -10.02 Mn
Dec 31, 2023 -10.02 Mn